IceCure Medical Ltd
IceCure Medical Ltd (ICCM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ICCM · as of Jun 9, 2026
Key Statistics
Explore IceCure Medical Ltd Data
iccm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
The ICCM analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $1.00, representing -72.53% downside from the current price of $3.64.
Competitors & Peers
iccm competitorsICCM
BDMD
CTSO
ECOR
MDAI
MDCXStock Performance
Full HistoryAbout IceCure Medical Ltd
IceCure Medical Ltd Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumor…
what is icecure medical ltd · iccm stock overview · icecure medical ltd company profile · who is icecure medical ltd ceo · iccm NASDAQ · icecure medical ltd headquarters · icecure medical ltd business segments
About Stock Overview & Key Data
IceCure Medical Ltd (ICCM) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Aug 26, 2021. As of the latest trading session, ICCM stock price is $3.64, with a market capitalization of $8.2M. The stock has returned -88.33% over the past 12 months and -80.11% year-to-date.
According to 3 Wall Street analysts, the consensus rating for IceCure Medical Ltd stock is Buy, with an average 12-month price target of $1.00. In fiscal year 2025, IceCure Medical Ltd reported revenue of $3.4M and net income of -$15.1M. For detailed data — including IceCure Medical Ltd revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, IceCure Medical Ltd (ICCM) stock price is $3.64. The stock is traded on NASDAQ under the ticker symbol ICCM. The 52-week range is $3.62 – $42.00.